Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 50 filings·Updated 22 Aug 2026
Showing 10 of 50 filings.
22 Aug 20262 filings
Company UpdateCopy of Newspaper Publication

Relaxo Footwears Limited has informed the Exchange about copy of Newspaper Publication regarding 42nd Annual General Meeting of the Company to be held on Thursday, September 24, 2026 at 10:30 A.M. (IST) through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM").

Filed 09:11View Source
Company UpdateNewspaper Publication

Newspaper Publication regarding 42nd AGM to be held on Thursday, September 24, 2026 at 10:30 A.M. (IST) through VC/ OVAM

Filed 09:07View Source
14 Aug 20262 filings
Company UpdateNewspaper Publication

Newspaper Publication

Filed 13:58View Source
Company UpdateCopy of Newspaper Publication

Relaxo Footwears Limited has informed the Exchange about Copy of Newspaper Publication

Filed 13:57View Source
13 Aug 20265 filings
Company UpdateGeneral

Relaxo approves grant of 5,03,500 ESOPs under Phase-V of ESOP Plan-2014 to eligible employees

ESOP grant details

  • NRC approved grant of 5,03,500 ESOPs under Phase-V of RFL ESOP Plan-2014 to eligible employees.
  • Options are convertible into an equal number of equity shares with face value Re 1.
  • Exercise price will be latest closing price prior to the grant date on the exchange with highest volume.
  • All vested options are exercisable within four years from the vesting date.
  • Vesting status for these options is not applicable.
  • Total shares covered by the grant are 5,03,500.
  • ESOP 2014 is administered by the Nomination and Remuneration Committee; eligibility criteria apply.
  • No options exercised or money realized to date.
  • Annexure with regulatory disclosures attached per SEBI LODR requirements.
  • Meeting date: August 13, 2026.
Filed 17:59View Source
Company UpdateInvestor Presentation

Relaxo FY27 Q1: revenue ₹705 Cr, EBITDA ₹108 Cr; capacity revised to 9.1 lakh pairs/day

Business Overview

  • Core business: Indian footwear manufacturer with in-house production across 9 facilities.
  • Capacity recalibrated to 9.1 lakh pairs/day as of Aug 13, 2026 board decision.
  • Pan-India distribution: ~630 General Trade distributors, 429 exclusive brand outlets (EBOs); exports to ~37 countries.
  • Overseas presence with Dubai office; AJIO and Meesho partnerships.

Operational Highlights

  • Q1 FY27 revenue ₹705.05 Cr; YoY growth 7.73%.
  • Q1 FY27 EBITDA ₹108.23 Cr; margin 15.35%.
  • Q1 FY27 PAT ₹54.94 Cr; margin 7.79%.
  • FY26 revenue ₹2,702.16 Cr; EBITDA ₹373.98 Cr; PAT ₹179.27 Cr.
  • FY26 EBITDA margin 13.84%; PAT margin 6.63%.
  • Capacity recalibration to 9.1 lakh pairs/day per Aug 13, 2026 board outcome.

Financial Position

  • Total assets FY26 ₹2,948.94 Cr; Net worth ₹2,206.36 Cr; cash ₹17.69 Cr.
  • Borrowings nil; lease liabilities ₹187.67 Cr (non-current) and ₹44.98 Cr (current).
  • Exports and distribution support liquidity; no borrowings reported.

Capital Structure & Liquidity

  • Market cap ₹10,100.68 Cr; EV ₹10,096 Cr; free float 28.73%; shares outstanding 24.89 Cr.
  • 52-week high ₹518.85; low ₹237.90; 3M ADTV 12,56,177 shares.

Strategic Priorities & Governance

  • Strategy: scale via in-house manufacturing; expand channels (GT, EBO, e-commerce); strengthen exports.
  • Leadership: Ramesh Kumar Dua (Chairman & MD); Gaurav Kumaar Dua (Co-CEO); Amit Roy (CFO).
  • Certifications and IP: ISO 9001/14001/45001/27001; 87 trademarks; 13 copyrights; 1,390 designs.
Filed 17:40View Source
Company UpdateInvestor Presentation

Relaxo FY1Q27 revenue ₹705 cr; capacity recalibrated to 9.1 lakh pairs/day after Aug 13, 2026 board update

Business overview

  • Diversified, in-house footwear manufacturer across India with 9 facilities.
  • Pan-India distribution network: ~630 distributors and 429 EBOs.
  • Exports to ~37 countries; online/offline channels incl. AJIO, Meesho.
  • Board-approved capacity recalibration to 9.1 lakh pairs/day (Aug 13, 2026).
  • ISO and other certifications; strong governance and brand IP portfolio.

Key operational highlights

  • Capacity recalibrated to 9.1 lakh pairs/day; upgrading facilities (RFL-I & II).
  • In-house manufacturing enables end-to-end quality control.
  • Strong e-commerce and modern trade reach; dedicated lines for fast-moving SKUs.

Financial performance

  • Q1 FY27 revenue ₹705.05 Cr; EBITDA ₹108.23 Cr; PAT ₹54.94 Cr.
  • Q1 FY27 EBITDA margin 15.35%; PAT margin 7.79%.
  • FY26 revenue ₹2,702.16 Cr; EBITDA ₹373.98 Cr; PAT ₹179.27 Cr; margins as noted.

Capital structure & liquidity

  • No borrowings reported; cash & cash equivalents ₹17.69 Cr.
  • Equity ₹24.89 Cr; total equity & liabilities ₹2,948.94 Cr (FY26).
  • ICRA AA/A1+ ratings; robust balance-sheet metrics.

Strategic priorities & outlook

  • Focus on fashion-forward, value-driven growth through diversified product mix.
  • Continued manufacturing efficiency; cost optimization; lean operations.
  • Strengthen distribution and online channels; expand overseas presence.

Governance & leadership

  • Board includes Ramesh Kumar Dua (Chairman & MD) and Co-CEOs; strong management team.
  • Shareholder base shows free float ~28.7%; governance with independent directors.
Filed 17:32View Source
Company UpdatePress Release / Media Release

Relaxo Footwears reports Q1 FY27 revenue Rs 705 crore; retail network to reach 500 stores

Financial Highlights

  • Q1 FY27 revenue Rs 705 crore, up 7.7% YoY.
  • EBITDA Rs 108 crore, up 8.8% YoY; margin 15.4%.
  • PAT Rs 55 crore; up 12.4% YoY; PAT margin 7.8%.

Strategic Focus & Outlook

  • Expansion plan to reach about 500 stores by year end.
  • Focus on cost optimization, product mix improvements, and operational efficiencies.
  • Positive demand environment; optimistic outlook for growth across channels.
Filed 17:31View Source
ResultFinancial Results

Relaxo Footwears Q1 2026: Revenue ₹705.05 Cr, PAT ₹54.94 Cr, EPS ₹2.21

Financial highlights

  • Revenue from operations: ₹705.05 Cr; total income: ₹718.01 Cr.
  • Total expenses: ₹642.93 Cr; profit before tax: ₹75.08 Cr.
  • Tax expense: ₹20.14 Cr; profit for the period: ₹54.94 Cr.
  • Basic and diluted EPS: ₹2.21.
  • Single operating segment: Footwear and Related Products.
  • Limited review by Gupta & Dua; report unmodified.
  • Quarter ended 30 June 2026; unaudited results.
Filed 16:53View Source
12 Aug 20261 filing
Company UpdateGeneral

Relaxo Footwears reports zero transfer/demat requests under SEBI window as of July 31, 2026

Status of transfer and dematerialisation requests

  • No transfer/demat requests were received or processed during June 1 to July 31, 2026, under SEBI window.
Filed 18:15View Source
Showing 10 of 50 filings